Obsidian Therapeutics, Inc. Common Stock (OBX) — Defensive Interval Ratio
Obsidian Therapeutics, Inc. Common Stock (OBX) has a Defensive Interval Ratio of 775 days as of March 2026. Defensive assets of $32.32 Million (cash $-, short-term investments $32.32 Million, receivables $-) cover 775 days of daily cash needs of $41.72K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Obsidian Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Obsidian Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at 775 days, meaning defensive assets of $32.32 Million can fund 775 days of operations without new revenue. For the complete balance sheet picture, see total assets of Obsidian Therapeutics, Inc. Common Stock.
Annual Defensive Interval Ratio for Obsidian Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Obsidian Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See OBX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 952 days | $40.08 Million | $42.09K/day | $- | $40.08 Million | ▼ -1737 days |
| 2024 | 2689 days | $118.51 Million | $44.07K/day | $- | $118.51 Million | — |